Purple Biotech Ltd. (PPBT.TA)
ILA 6.9
(-4.17%)
ILA 6.9
(-4.17%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -19.88 Thousand USD | 99.91% |
| 2022 | -21.66 Million USD | -17.86% |
| 2021 | -18.38 Million USD | 34.34% |
| 2020 | -27.99 Million USD | -378.62% |
| 2019 | -5.85 Million USD | -12.5% |
| 2018 | -5.2 Million USD | 57.63% |
| 2017 | -12.27 Million USD | -1.21% |
| 2016 | -12.12 Million USD | -188.55% |
| 2015 | -4.2 Million USD | 19.99% |
| 2014 | -5.25 Million USD | -99.85% |
| 2013 | -2.62 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.76 Million USD | 22.08% |
| 2024 Q2 | -2.4 Million USD | 36.07% |
| 2023 Q4 | -4.82 Million USD | 4.13% |
| 2023 FY | -19.88 Thousand USD | 99.91% |
| 2023 Q1 | -4.87 Million USD | 18.85% |
| 2023 Q2 | -5.13 Million USD | -5.33% |
| 2023 Q3 | -5.03 Million USD | 1.99% |
| 2022 Q3 | -4.82 Million USD | -36.43% |
| 2022 Q4 | -6.01 Million USD | -24.61% |
| 2022 FY | -21.66 Million USD | -17.86% |
| 2022 Q1 | -7.29 Million USD | -43.87% |
| 2022 Q2 | -3.53 Million USD | 51.54% |
| 2021 Q4 | -5.07 Million USD | -61.68% |
| 2021 Q1 | -6.54 Million USD | -788.33% |
| 2021 Q3 | -3.13 Million USD | 13.53% |
| 2021 FY | -18.38 Million USD | 34.34% |
| 2021 Q2 | -3.62 Million USD | 44.59% |
| 2020 Q4 | -737 Thousand USD | -570.0% |
| 2020 Q3 | -110 Thousand USD | 99.21% |
| 2020 Q2 | -13.88 Million USD | 0.0% |
| 2020 Q1 | -13.88 Million USD | -1105.16% |
| 2020 FY | -27.99 Million USD | -378.62% |
| 2019 Q4 | -1.15 Million USD | 29.62% |
| 2019 Q2 | -1.28 Million USD | 0.0% |
| 2019 Q1 | -1.28 Million USD | -642.07% |
| 2019 FY | -5.85 Million USD | -12.5% |
| 2019 Q3 | -1.63 Million USD | -27.18% |
| 2018 Q4 | -173.5 Thousand USD | 0.0% |
| 2018 FY | -5.2 Million USD | 57.63% |
| 2018 Q3 | -173.5 Thousand USD | 92.85% |
| 2018 Q2 | -2.42 Million USD | 0.0% |
| 2018 Q1 | -2.42 Million USD | 23.61% |
| 2017 Q3 | -3.17 Million USD | -9.08% |
| 2017 FY | -12.27 Million USD | -1.21% |
| 2017 Q4 | -3.17 Million USD | 0.0% |
| 2017 Q1 | -2.91 Million USD | 35.92% |
| 2017 Q2 | -2.91 Million USD | 0.0% |
| 2016 Q2 | -1.51 Million USD | 0.0% |
| 2016 Q4 | -4.54 Million USD | 0.0% |
| 2016 FY | -12.12 Million USD | -188.55% |
| 2016 Q1 | -1.51 Million USD | -20.13% |
| 2016 Q3 | -4.54 Million USD | -199.24% |
| 2015 FY | -4.2 Million USD | 19.99% |
| 2015 Q4 | -1.26 Million USD | -0.64% |
| 2015 Q3 | -1.25 Million USD | -32.91% |
| 2015 Q2 | -945 Thousand USD | -28.22% |
| 2015 Q1 | -737 Thousand USD | 7.76% |
| 2014 Q3 | -1.24 Million USD | 29.68% |
| 2014 Q4 | -799 Thousand USD | 35.77% |
| 2014 Q2 | -1.76 Million USD | -22.85% |
| 2014 FY | -5.25 Million USD | -99.85% |
| 2014 Q1 | -1.44 Million USD | -351.41% |
| 2013 Q2 | -216 Thousand USD | -81.51% |
| 2013 FY | -2.62 Million USD | 0.0% |
| 2013 Q4 | -319 Thousand USD | 83.84% |
| 2013 Q3 | -1.97 Million USD | -813.89% |
| 2013 Q1 | -119 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Matricelf Ltd | -12.48 Million ILA | 99.841% |